In one paragraphArticle in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Maria Vidal-SabanésDevelopmental and Oncogenic Signaling Group. Departament de Ciències Mèdiques Bàsiques/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.ORCID http://orcid.org/0000-0003-4154-6061 Núria BonifaciMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Joaquim EgeaDevelopmental and Oncogenic Signaling Group. Departament de Ciències Mèdiques Bàsiques/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.
Mario EncinasDevelopmental and Oncogenic Signaling Group. Departament de Ciències Mèdiques Bàsiques/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.
Ruth Rodriguez-BarruecoMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4925-8865 Jose M SilvaDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Xavier Matias-GuiuCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, Spain.
Jordi TarragonaOncologic Pathology Group. Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.
David Llobet-NavasMolecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. dllobet@idibell.cat.ORCID http://orcid.org/0000-0003-1443-7003 Xavier DolcetDevelopmental and Oncogenic Signaling Group. Departament de Ciències Mèdiques Bàsiques/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain. xavi.dolcet@udl.cat.ORCID http://orcid.org/0000-0003-1921-0449 Funding
Ministerio de Educación, Cultura y Deporte (Ministry of Education, Culture and Sports, Spain) PID2022-141220OB-I00Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI21/00672Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI24/01255
6 · The paper itselfAbstract
Colorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality worldwide, with molecular subtypes and signaling pathways playing critical roles in its progression. The miR-424(322)
Indexed as
Colonic NeoplasmsMicroRNAsPTEN PhosphohydrolaseAnimalsCell ProliferationDisease ProgressionEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansMiceMice, KnockoutWnt Signaling PathwayMicroRNAsMIRN424 microRNA, mouseMirn503 microRNA, mousePTEN PhosphohydrolasePten protein, mouse
Identifiers
PMID41730834
PMCPMC12966372
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390